- Home
- INTG vs BCAB Comparison
INTG vs BCAB Comparison
Compare INTG & BCAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTG
- BCAB
- Stock Information
- Founded
- INTG 1965
- BCAB 2007
- Country
- INTG United States
- BCAB United States
- Employees
- INTG N/A
- BCAB N/A
- Industry
- INTG Building operators
- BCAB Medicinal Chemicals and Botanical Products
- Sector
- INTG Real Estate
- BCAB Health Care
- Exchange
- INTG Nasdaq
- BCAB Nasdaq
- Market Cap
- INTG 24.0M
- BCAB 21.6M
- IPO Year
- INTG N/A
- BCAB 2020
- Fundamental
- Price
- INTG $17.42
- BCAB $0.54
- Analyst Decision
- INTG
- BCAB Hold
- Analyst Count
- INTG 0
- BCAB 3
- Target Price
- INTG N/A
- BCAB $1.00
- AVG Volume (30 Days)
- INTG 4.0K
- BCAB 665.1K
- Earning Date
- INTG 09-29-2025
- BCAB 11-06-2025
- Dividend Yield
- INTG N/A
- BCAB N/A
- EPS Growth
- INTG N/A
- BCAB N/A
- EPS
- INTG N/A
- BCAB N/A
- Revenue
- INTG $61,597,000.00
- BCAB $11,000,000.00
- Revenue This Year
- INTG N/A
- BCAB N/A
- Revenue Next Year
- INTG N/A
- BCAB N/A
- P/E Ratio
- INTG N/A
- BCAB N/A
- Revenue Growth
- INTG 6.76
- BCAB N/A
- 52 Week Low
- INTG $9.57
- BCAB $0.24
- 52 Week High
- INTG $19.24
- BCAB $2.53
- Technical
- Relative Strength Index (RSI)
- INTG 68.92
- BCAB 72.68
- Support Level
- INTG $13.31
- BCAB $0.44
- Resistance Level
- INTG $18.76
- BCAB $0.46
- Average True Range (ATR)
- INTG 0.81
- BCAB 0.04
- MACD
- INTG 0.42
- BCAB 0.02
- Stochastic Oscillator
- INTG 79.42
- BCAB 96.87
About INTG Intergroup Corporation (The)
The Intergroup Corp is an us-based company operating in the real estate sector. It is formed to buy, develop, operate, rehabilitate and dispose of real property of various types and descriptions, and to engage in other related business and investment activities. The company operates through three segments namely Hotel Operations, Real Estate Operations, and Investment Transactions. The Hotel Operations segment which generates the majority of the revenue covers the operation of the Hilton hotel and garage. The Real Estate Operations segment consists of the operation of multifamily rental properties whereas the Investment Transactions segment includes an investment of cash in marketable securities and other investments.
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.